(S)-2-(5-(3,7-dimethylocta-2,6-dienyl)-2-hydroxy-4-methoxyphenyl)-5,7-dihydroxychroman-4-one

ID: ALA1096940

PubChem CID: 46209782

Max Phase: Preclinical

Molecular Formula: C26H30O6

Molecular Weight: 438.52

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(O)c([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1C/C=C(\C)CCC=C(C)C

Standard InChI:  InChI=1S/C26H30O6/c1-15(2)6-5-7-16(3)8-9-17-10-19(20(28)13-23(17)31-4)24-14-22(30)26-21(29)11-18(27)12-25(26)32-24/h6,8,10-13,24,27-29H,5,7,9,14H2,1-4H3/b16-8+/t24-/m0/s1

Standard InChI Key:  CZVSHXUUSIQWSO-CECMFTGFSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
    7.5991   -7.6328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5959   -8.4589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3137   -8.8744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3110   -7.2199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0283   -7.6314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0293   -8.4645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7481   -8.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4688   -8.4556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4678   -7.6225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7419   -7.2090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7515   -9.7002    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1775   -7.2108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8942   -7.6231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6073   -7.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6041   -6.3820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8829   -5.9731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1742   -6.3873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4578   -5.9782    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3233   -7.6183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0363   -7.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7522   -7.6132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4652   -7.1982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7551   -8.4382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1811   -7.6082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8941   -7.1932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6101   -7.6031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3231   -7.1881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6130   -8.4281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0330   -6.3799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3123   -9.6990    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8838   -7.2201    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3179   -5.9684    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  9 12  1  6
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
  1  2  2  0
 14 19  1  0
  2  3  1  0
 19 20  1  0
  3  6  2  0
 20 21  2  0
  5  4  2  0
 21 22  1  0
  4  1  1  0
 21 23  1  0
  5  6  1  0
 22 24  1  0
  5 10  1  0
 24 25  1  0
  6  7  1  0
 25 26  2  0
  7  8  1  0
 26 27  1  0
  8  9  1  0
 26 28  1  0
  9 10  1  0
  7 11  2  0
  1 31  1  0
  3 30  1  0
 15 32  1  0
 32 29  1  0
M  END

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-266 (527 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJ (6930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ATP2A1 Sarcoplasmic/endoplasmic reticulum calcium ATP-ase (121 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Atp2a1 Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.52Molecular Weight (Monoisotopic): 438.2042AlogP: 5.75#Rotatable Bonds: 7
Polar Surface Area: 96.22Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.84CX Basic pKa: CX LogP: 6.07CX LogD: 5.93
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.48Np Likeness Score: 2.33

References

1. Smejkal K, Svacinová J, Slapetová T, Schneiderová K, Dall'acqua S, Innocenti G, Závalová V, Kollár P, Chudík S, Marek R, Julínek O, Urbanová M, Kartal M, Csöllei M, Dolezal K..  (2010)  Cytotoxic activities of several geranyl-substituted flavanones.,  73  (4): [PMID:20192247] [10.1021/np900681y]
2. Heger V, Benesova B, Viskupicova J, Majekova M, Zoofishan Z, Hunyadi A, Horakova L..  (2020)  Phenolic Compounds from Morus nigra Regulate Viability and Apoptosis of Pancreatic β-Cells Possibly via SERCA Activity.,  11  (5): [PMID:32435418] [10.1021/acsmedchemlett.0c00047]

Source